drugset / Trial / NCT03347968

Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382

NCT03347968

Phase 1 Completed 22 enrolled MedImmune LLC
Non-randomizedCrossoverOpen-labelTreatment

Summary

A Phase 1 study to evaluate the effect of MEDI0382 on PK and PD of warfarin and esmolol in healthy subjects.

Timeline

Start
2017-11-27
Primary completion
2018-04-09
Completion
2018-04-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Cotadutide Peptide
Comparator Esmolol Other / unclassified
Comparator Warfarin Small molecule

Indications

No indication recorded.